Leerink Swann Downgrades BioSante Pharmaceuticals (BPAX) to Market Perform; Pivotal BLOOM Trials Surprisingly Disappoint

Go back to Leerink Swann Downgrades BioSante Pharmaceuticals (BPAX) to Market Perform; Pivotal BLOOM Trials Surprisingly Disappoint
Abbott Laboratories (NYSE: ABT) Delayed: 116.64 +2.50 (2.19%)
Previous Close $114.14    52 Week High $46.38 
Open $114.02    52 Week Low $36.00 
Day High $116.66    P/E 77.76 
Day Low $113.45    EPS $1.50 
Volume 10,931,175       

BIOSANTE PHARM (NASDAQ: BPAX) Delayed: 1.09 --0 (-0%)
Previous Close $1.09    52 Week High $2.20 
Open $1.09    52 Week Low $0.80 
Day High $1.09    P/E N/A 
Day Low $1.09    EPS $-0.85 
Volume 2,100       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 37.34 +0.53 (1.44%)
Previous Close $36.81    52 Week High $66.55 
Open $36.79    52 Week Low $37.82 
Day High $37.75    P/E N/A 
Day Low $36.65    EPS $0.00 
Volume 4,300,152